Goodwin Procter LLP are most popular:
- within Transport and Strategy topic(s)
To help companies and investors navigate the many evolving and emerging laws and regulations across pharmaceuticals, biologics, medical devices, diagnostics, and laboratory testing, our Life Sciences Regulatory & Compliance team has provided an overview of key developments. We update and publish a quarterly tracker detailing these developments. You can read about the Q1 2025 updates here.
The post A Look Ahead in Life Sciences: What We Are Tracking in the First Quarter of 2025 and Beyond appeared first on Life Sciences Perspectives.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
